Two new Health Canada guidance documents about bioavailability

Bioavailability is an important attribute of formulations of drugs used for systemic effects. It is defined as the rate and extent of drug entry into the systemic circulation. Health Canada has released two guidance documents, entitled Conduct and Analysis of Comparative Bioavailability Studies and Comparative Bioavailability Standards: Formulations used for Systemic Effects.